Format

Send to

Choose Destination
Expert Opin Investig Drugs. 2014 Apr;23(4):523-39. doi: 10.1517/13543784.2014.892582. Epub 2014 Feb 21.

Saponins of Panax notoginseng: chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases.

Author information

1
University of Macau, Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine , Avenida Padre Tomas Pereira, Taipa, Macau , China YTWang@umac.mo ; CMWang@umac.mo.

Abstract

INTRODUCTION:

Among the notable breakthroughs in the past two decades of research in natural drug discovery is the identification of saponins (saponins in Panax notoginseng, PNS) as the primary ingredient of Panax notoginseng, an iconic herbal medicine in East Asia. Increasing evidences suggest that PNS have versatile effects against a variety of cardiovascular diseases (CVDs), leading to four clinical trials completed and/or underway. There is a timely need to summarize our current understanding of these natural compounds.

AREAS COVERED:

In this review, the authors summarize and critically appraise the latest literature (mainly since 2008), which study PNS as potential therapeutic agents against CVDs. Furthermore, they introduce the structures of major PNS types, analyze their cellular targets and associated signaling pathways and discuss the emerging opportunities for their clinical applications. A major focus here is on how these compounds affect the cardiovascular system via diverse mechanisms of action.

EXPERT OPINION:

The authors believe that future research should head in two directions. The first direction taken should involve establishing a PNS compounds library to correlate their functions with structures; the second direction should be by integrating network pharmacology and pharmaceutical techniques in the future development of these natural compounds as new vascular medicine.

PMID:
24555869
DOI:
10.1517/13543784.2014.892582
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center